SCHEMBL5577959

SCHEMBL5577959

Cc1ncn(-c2n[nH]c3nc(C(N)=O)sc23)c1-c1ccccc1Cl

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.35
PLK1 P53350 2/20 0.33
CSNK2A2 P19784 1/20 0.33
KDR P35968 1/20 0.33
CSNK2B P67870 1/20 0.33
CSNK2A1 P68400 1/20 0.33
HSD17B10 Q99714 1/20 0.33
SLC9A1 P19634 1/20 0.32
GRM2 Q14416 1/20 0.32
KMT2A Q03164 1/20 0.32
HSD11B1 P28845 1/20 0.32
MKNK1 Q9BUB5 1/20 0.32
MKNK2 Q9HBH9 1/20 0.32
DPP4 P27487 1/20 0.32
DPP8 Q6V1X1 1/20 0.32
PAK1 Q13153 1/20 0.31
NPC1 O15118 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5577966 0.85 HSD11B1 (0.35) JAK2HSD17B10KMT2AHSD11B1NPC1
SCHEMBL5577939 0.82 HSD11B1 (0.36) JAK2PLK1CSNK2A2KDRCSNK2B
SCHEMBL14454988 0.82 NPC1 (0.46) KMT2ANPC1RAB9AMAPK11MAPK14
SCHEMBL5577960 0.80 GPBAR1 (0.36) JAK2PLK1CSNK2A2KDRCSNK2B
SCHEMBL5577962 0.68 SCN9A (0.32) HSD17B10KMT2AALDH1A1SCN9A
SCHEMBL5577957 0.66 LIMK1 (0.44) KDRHSD17B10KMT2ANPC1ALDH1A1
SCHEMBL5577941 0.65 HSD11B1 (0.40) JAK2HSD17B10HSD11B1NPC1ALDH1A1
SCHEMBL5578177 0.65 DYRK1A (0.32)
SCHEMBL3501617 0.65 GRM2 (0.38) HSD17B10GRM2KMT2ANPC1ALDH1A1
SCHEMBL4753950 0.65 CA1 (0.41) KMT2ANPC1ALDH1A1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators SGX PHARMACEUTICALS, INC. (US) 2007-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators MAP4K2, MAP4K5, MAP4K3 JAK2 182/4885PLK1 81/4885CSNK2A2 145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.